Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Rivaroxaban 10mg tablets

Brand: Xarelto®
NICE TA: 
Indication: Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Rivaroxaban 10mg is recommended for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and extended prevention of recurrent DVT and PE in adults after initial treatment, as described in NICE TA261.
• Suitable for prescribing in primary care following recommendation or initiation by a specialist.
• Little or no specific monitoring required.
• Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
• Brief prescribing document or information sheet may be required.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

LMMG New Medicine Recommendation - Rivaroxaban 10mg (222.2 KiB)

NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber0

Amber0

Amber0

Amber0

Amber0